Work

Ivacaftor in a G551D Homozygote with Cystic Fibrosis

Year: 2013
Type: article
Abstract: Ivacaftor, an oral potentiator of the cystic fibrosis transmembrane conductance regulator (CFTR) protein, has been shown to be efficacious in patients heterozygous for the G551D mutation in CFTR. This letter describes the effect of ivacaftor in a patient homozygous for this mutation.
Authors: Michael J. Harrison, Desmond M. Murphy, Barry J. Plant
Language: English
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2321608101
FWCI: 6.732
Cites: 2
Cited by: 63
Related to: 10